This page includes the latest FDA filings for Retrophin Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | RTRX | DUNS 965454502 |
Device Company | Device | Date |
|---|---|---|
| Travere Therapeutics, LGM Pharma LLC | Prescription Medication | 2024-12-10 |
| Travere Therapeutics, LGM Pharma LLC | Prescription Medication | 2023-07-08 |
| Manchester Pharmaceuticals, LLC, Travere Therapeutics, Inc, Patheon France S.A.S | Prescription Medication | 2023-04-04 |
| Manchester Pharmaceuticals, LLC, Travere Therapeutics, Inc, Patheon France S.A.S | Prescription Medication | 2022-11-18 |
| Travere Therapeutics, LGM Pharma LLC | Prescription Medication | 2021-12-02 |
| Manchester Pharmaceuticals, LLC, Travere Therapeutics, Inc, Patheon France S.A.S | Prescription Medication | 2021-11-30 |
| Travere Therapeutics, LGM Pharma LLC | Prescription Medication | 2021-08-11 |
| Manchester Pharmaceuticals, LLC, Travere Therapeutics, Inc, Patheon France S.A.S | Prescription Medication | 2020-12-15 |
| Travere Therapeutics, LGM Pharma LLC | Prescription Medication | 2020-12-11 |
| Travere Therapeutics, LGM Pharma LLC | Prescription Medication | 2020-06-13 |
| Manchester Pharmaceuticals, LLC, Travere Therapeutics, Inc, Patheon France S.A.S | Prescription Medication | 2020-06-12 |
| Manchester Pharmaceuticals, LLC, Travere Therapeutics, Inc, Patheon France S.A.S | Prescription Medication | 2019-07-13 |
| Travere Therapeutics, LGM Pharma LLC | Prescription Medication | 2019-07-13 |
| Retrophin, Inc. | Chenodal | 2015-12-28 |
| Retrophin, Inc | Cholbam | 2015-03-31 |
| Retrophin, Inc | Cholbam | 2015-03-31 |
| NCAGE Code | 77HN5 | RETROPHIN, INC. |
| CAGE Code | 77HN5 | RETROPHIN, INC. |
| S.A.M. Registration | 77HN5 [965454502] | RETROPHIN, INC. |
| SEC | 0001438533 | Retrophin, Inc. of DELAWARE |